Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bloomston

Showing results (121-130 of 189) with videos related to

Pageof 19
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 23, 2015
Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse OutcomesJill K Onesti, Lawrence A Shirley, Neil D Saunders, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 4, 2014
The value of drains as a fistula mitigation strategy for pancreatoduodenectomy: something for everyone? Results of a randomized prospective multi-institutional studyMatthew T McMillan, William E Fisher, George Van Buren, et al.
Oncotarget|November 18, 2015
Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancerThomas A Mace, Reena Shakya, Omar Elnaggar, et al.
Pancreas|May 3, 2021
Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes DatabaseHilary Chan, Li Zhang, Michael A Choti, et al.
Journal of Clinical Pharmacology|January 25, 2007
Population pharmacokinetics of humanized monoclonal antibody HuCC49deltaCH2 and murine antibody CC49 in colorectal cancer patientsLanyan Fang, Nicholas H G Holford, George Hinkle, et al.
Scientific Reports|May 13, 2017
Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivoHannah M Komar, Gregory Serpa, Claire Kerscher, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2015
Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinomaLaura K Aguilar, Lawrence A Shirley, Vincent M Chung, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 13, 2008
32P as an adjunct to standard therapy for locally advanced unresectable pancreatic cancer: a randomized trialAlexander Rosemurgy, German Luzardo, Jennifer Cooper, et al.
International Journal of Radiation Oncology, Biology, Physics|July 24, 2012
A dose escalation and pharmacodynamic study of triapine and radiation in patients with locally advanced pancreas cancerLudmila Katherine Martin, John Grecula, Guang Jia, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 11, 2014
A multi-institutional analysis of open versus minimally-invasive surgery for gastric adenocarcinoma: results of the US gastric cancer collaborativeGaya Spolverato, Yuhree Kim, Aslam Ejaz, et al.
Pageof 19

Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 23, 2015
Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse OutcomesJill K Onesti, Lawrence A Shirley, Neil D Saunders, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 4, 2014
The value of drains as a fistula mitigation strategy for pancreatoduodenectomy: something for everyone? Results of a randomized prospective multi-institutional studyMatthew T McMillan, William E Fisher, George Van Buren, et al.
Oncotarget|November 18, 2015
Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancerThomas A Mace, Reena Shakya, Omar Elnaggar, et al.
Pancreas|May 3, 2021
Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes DatabaseHilary Chan, Li Zhang, Michael A Choti, et al.
Journal of Clinical Pharmacology|January 25, 2007
Population pharmacokinetics of humanized monoclonal antibody HuCC49deltaCH2 and murine antibody CC49 in colorectal cancer patientsLanyan Fang, Nicholas H G Holford, George Hinkle, et al.
Scientific Reports|May 13, 2017
Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivoHannah M Komar, Gregory Serpa, Claire Kerscher, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2015
Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinomaLaura K Aguilar, Lawrence A Shirley, Vincent M Chung, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 13, 2008
32P as an adjunct to standard therapy for locally advanced unresectable pancreatic cancer: a randomized trialAlexander Rosemurgy, German Luzardo, Jennifer Cooper, et al.
International Journal of Radiation Oncology, Biology, Physics|July 24, 2012
A dose escalation and pharmacodynamic study of triapine and radiation in patients with locally advanced pancreas cancerLudmila Katherine Martin, John Grecula, Guang Jia, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 11, 2014
A multi-institutional analysis of open versus minimally-invasive surgery for gastric adenocarcinoma: results of the US gastric cancer collaborativeGaya Spolverato, Yuhree Kim, Aslam Ejaz, et al.
Pageof 19